For instance, tumor cell antigen modulation allows the cells to escape from recognition by T cells and NK cells, thereby downregulating T cell- and NK cell-related immune factors (IL18 and CD300A)[39, 40]. The gene discussed is CD300A; the disease is neoplasm.